{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:52:21Z","timestamp":1778781141685,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Fusarium<\/jats:italic> species are saprophytic fungi with a worldwide distribution. These fungi cause various infections among immunocompromised patients; however, they can also involve immunocompetent individuals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a case of a 41-year-old\u00a0Iranian woman who presented with ulcerative lesions on her lips 10\u00a0months ago. She had a long history of anxiety but had no history of classical risk factors such as trauma, cosmetic lip tattoo, burning in her lips, smoking or use of alcohol and opium. A skin biopsy from the lower lip was performed and sent for microbiological examinations. Hyaline septate hyphae were seen on direct microscopy with potassium hydroxide. The clinical specimen was subcultured on sabouraud dextrose agar with chloramphenicol and prepared for antifungal susceptibility testing and molecular identification. Considering the minimum inhibitory concentrations (MIC) for antifungals, itraconazole (100\u00a0mg orally twice a day) was started for her, and after 2\u00a0months, the lesions were treated. She followed up for 3\u00a0months, and no signs of disease recurrence were observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Selecting an appropriate treatment strategy according to the laboratory assessments is essential in clinical practice and the management of rare infections to prevent related mortality and morbidity of opportunistic fungal infections.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03575-5","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T23:04:02Z","timestamp":1664492642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Fatemeh","family":"Mohaghegh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahareh","family":"Abtahi-Naeini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe","family":"Nasri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Badiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Morovati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Fakhim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Farmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Meidani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Ranjbar-Mobarake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8220-4511","authenticated-orcid":false,"given":"Rasoul","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"3575_CR1","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s10096-014-2111-1","volume":"33","author":"A Tortorano","year":"2014","unstructured":"Tortorano A, Prigitano A, Esposto M, Arsic Arsenijevic V, Kolarovic J, Ivanovic D, et al. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis. 2014;33:1623\u201330.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3575_CR2","doi-asserted-by":"publisher","first-page":"300060520976475","DOI":"10.1177\/0300060520976475","volume":"48","author":"SY Chae","year":"2020","unstructured":"Chae SY, Park HM, Oh TH, Lee JE, Lee HJ, Jeong WG, et al. Fusarium species causing invasive fungal pneumonia in an immunocompetent patient: a case report. J Int Med Res. 2020;48:300060520976475.","journal-title":"J Int Med Res"},{"key":"3575_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00014-07","volume":"20","author":"M Nucci","year":"2007","unstructured":"Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20:695\u2013704.","journal-title":"Clin Microbiol Rev"},{"key":"3575_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1067\/mjd.2002.123489","volume":"47","author":"GP Bodey","year":"2002","unstructured":"Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem R, et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002;47:659\u201366.","journal-title":"J Am Acad Dermatol"},{"key":"3575_CR5","unstructured":"Clinical laboratory standards institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 3rd ed; approved standard. CLSI document M38. Wayne: Clinical and laboratory standards institute; 2017."},{"key":"3575_CR6","first-page":"315","volume":"18","author":"TJ White","year":"1990","unstructured":"White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR Protoc Guide Methods Appl. 1990;18:315\u201322.","journal-title":"PCR Protoc Guide Methods Appl"},{"key":"3575_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00001432-200004000-00005","volume":"13","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Baran R, Summerbell RC. Fusarium infections of the skin. Curr Opin Infect Dis. 2000;13:121\u20138.","journal-title":"Curr Opin Infect Dis"},{"key":"3575_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mycmed.2019.01.008","volume":"29","author":"T Radulesco","year":"2019","unstructured":"Radulesco T, Varoquaux A, Ranque S, Dessi P, Michel J, Cassagne C. Maxillary fungus balls due to Fusarium proliferatum. J Mycol Med. 2019;29:59\u201361.","journal-title":"J Mycol Med."},{"key":"3575_CR9","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/342328","volume":"35","author":"M Nucci","year":"2002","unstructured":"Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002;35:909\u201320.","journal-title":"Clin Infect Dis"},{"key":"3575_CR10","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1128\/JCM.43.10.5372-5375.2005","volume":"43","author":"C Ferrer","year":"2005","unstructured":"Ferrer C, Alio J, Rodriguez A, Andreu M, Colom F. Endophthalmitis caused by Fusarium proliferatum. J Clin Microbiol. 2005;43:5372\u20135.","journal-title":"J Clin Microbiol"},{"key":"3575_CR11","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.ad.2016.11.020","volume":"108","author":"C Aspiroz","year":"2017","unstructured":"Aspiroz C, Sevil M, Toyas C, Gilaberte Y. Photodynamic therapy with methylene blue for skin ulcers infected with Pseudomonas aeruginosa and Fusarium spp. Actas Dermosifiliogr. 2017;108:e45\u20138.","journal-title":"Actas Dermosifiliogr"},{"key":"3575_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jof3020019","volume":"3","author":"AMS Al-Hatmi","year":"2017","unstructured":"Al-Hatmi AMS, Curfs-Breuker I, de Hoog GS, Meis JF, Verweij PE. Antifungal susceptibility testing of fusarium: a practical approach. J Fungi (Basel). 2017;3:19.","journal-title":"J Fungi (Basel)."},{"key":"3575_CR13","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1128\/AAC.50.3.917-921.2006","volume":"50","author":"M Cuenca-Estrella","year":"2006","unstructured":"Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006;50:917\u201321.","journal-title":"Antimicrob Agents Chemother"},{"key":"3575_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1081\/PFC-100103573","volume":"36","author":"M Tzatzarakis","year":"2001","unstructured":"Tzatzarakis M, Tsatsakis A, Charvalos E, Vakalounakis D. Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum. J Environ Sci Health. 2001;36:331\u201340.","journal-title":"J Environ Sci Health"},{"issue":"76","key":"3575_CR15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/jac\/dkaa516","volume":"12","author":"M Nucci","year":"2021","unstructured":"Nucci M, Jenks J, Thompson GR, Hoenigl M, Dos Santos MC, Forghieri F, et al. Do high MICs predict the outcome in invasive fusariosis? J Antimicrob Chemother. 2021;12(76):1063\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"3575_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1365-2230.2009.03698.x","volume":"35","author":"JG Bueno","year":"2010","unstructured":"Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clin Exp Dermatol. 2010;35:658\u201363.","journal-title":"Clin Exp Dermatol"},{"key":"3575_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/jdv.12151","volume":"28","author":"LB Silva","year":"2014","unstructured":"Silva LB, de Oliveira DB, da Silva BV, de Souza RA, da Silva PR, Ferreira-Paim K, et al. Identification and antifungal susceptibility of fungi isolated from dermatomycoses. J Eur Acad Dermatol Venereol. 2014;28:633\u201340.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3575_CR18","first-page":"1068","volume":"70","author":"AM Al-Hatmi","year":"2015","unstructured":"Al-Hatmi AM, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, Meis JF. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. J Antimicrob Chemother. 2015;70:1068\u201371.","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03575-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03575-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03575-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T23:21:13Z","timestamp":1664493673000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03575-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3575"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03575-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Ethics Committee of Isfahan University of Medical Science (No. IR.MUI.MED.REC.1400.669), and written informed consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflict of interests or financial disclosures to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}